kw.\*:("LIPOSTABIL")
Results 1 to 6 of 6
Selection :
ZUM THERAPEUTISCHEN WERT DER ESSENTIELLEN PHOSPHOLIPIDE = VALEUR THERAPEUTIQUE DES PHOSPHOLIPIDES ESSENTIELSPRISTAUTZ H.1975; MUENCH. MED. WSCHR.; DTSCH.; DA. 1975; VOL. 117; NO 14; PP. 583-586; ABS. ANGL.; BIBL. 39REF.; (81. TAG. DTSCH. GES. INN. MED.; WIESBADEN; 1975)Conference Paper
ETUDE EXPERIMENTALE DE L'EFFET DU LIPOSTABIL SUR LA RETINE NORMALEOTAGURO S.1972; FOLIA OPHTHALMOL. JAP.; JAP.; DA. 1972; VOL. 23; NO 5; PP. 386-389; ABS. ANGL.; BIBL. 8REF.Serial Issue
UTILISATION DE PHOSPHOLIPIDES POLYINSATURES DANS LE TRAITEMENT DE L'EMBOLIE GRAISSEUSEWATTEL F; SCHERPEREEL P; SEZILLE G et al.1974; LILLE MED.; FR.; DA. 1974; VOL. 19; NO 8SUPPL.; PP. 870-874; BIBL. 18REF.Article
INHIBITION BY POLYUNSATURATED PHOSPHOLIPIDS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN THE GUINEA PIGSIMON J; CONTAG I; POELLINGER G et al.1979; J. NEUROL. SCI.; NLD; DA. 1979; VOL. 40; NO 2-3; PP. 113-122; BIBL. 1 P.Article
EFFECT OF SOYBEAN POLYUNSATURATED PHOSPHATIDYLCHOLINE (LIPOSTABILREG.) ON HYPERLIPOPROTEINEMIASABA P; GALEONE F; SALVADORINI F et al.1978; CURR. THERAPEUT. RES.; USA; DA. 1978; VOL. 24; NO 3; PP. 299-306; BIBL. 2 P.Article
Essential phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart diseaseKLIMOV, A. N; KONSTANTINOV, V. O; LIPOVETSKY, B. M et al.Cardiovascular drugs and therapy. 1995, Vol 9, Num 6, pp 779-784, issn 0920-3206Article